A Phase II, Randomized Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
A Phase II, Randomized Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
This multicenter, randomized, single-blind, placebo-controlled, two arm study will evaluate the efficacy and safety of paclitaxel with GDC-0941 versus paclitaxel with placebo in participants with locally recurrent or metastatic breast cancer.
Inclusion Criteria:
Exclusion Criteria:
Encinitas, California 92008, United States
Hartford, Connecticut 06102-5037, United States
Topeka, Kansas 66606, United States
Port Macquarie, New South Wales 2444, Australia
Wodonga, New South Wales 3690, Australia
Praha 4 - Krc, 140 59, Czechia